Evaluation of the advanced air mobility potential for organ transplantation in Austria and Germany

Solid organ transplantation continues to be the only or most efficient therapeutic solution for several end-stage diseases. The success of such transplantation is largely dependent on the swift transportation of organs from donors to recipients, as Cold Ischemia Time (CIT) plays a critical role in determining the recipient's medical outcome. This study explores the potential of Advanced Air Mobility (AAM) in the context of organ transplantation in Austria and Germany. AAM, in the healthcare sector, is associated with potential overall process time savings via air transportation, thereby reducing CIT. However, the application of AAM for organ transplantation has not yet been implemented in Europe. This study employs a Monte Carlo simulation to derive the trip length distributions for organ transplantation in Austria and Germany. By utilizing data from Eurotransplant (2018-2021) and ÖBIG (2017-2021), it was found that 48% of organ transports within Germany, and 80% of organ transports within Austria, fall within a trip length of less than 150 km. This distance is within the capabilities of today's AAM technology. Anticipated time benefits of up to 30 min compared to ground-based transport can be expected. Furthermore, the optimization of the organ transport process, facilitated by AAM, promises greater potential for CIT reduction.